Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Long term follow-up of the STOPAGO study

Blood blood.2024025707.

https://doi.org/10.1182/blood.2024025707

Published: 2024

Includes: Supplemental data

Journal Articles

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Blood (2023) 141 (23): 2867–2877.

https://doi.org/10.1182/blood.2022018665

Published: 2023

Includes: Supplemental data

Journal Articles

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Blood (2021) 138 (Supplement 1): 583.

https://doi.org/10.1182/blood-2021-152767

Published: 2021

Journal Articles

Biosimilar of Rituximab for the Treatment of Primary Immune Thrombocytopenic Purpura : A Case-Control Study

Arthur Mageau, MDMSc, Nicolas Limal, Constance Guillaud, MD, Laetitia Languille, Matthieu Mahevas, Marc Michel, Bertrand Godeau

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-139333

Published: 2020

Journal Articles

Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia

Bruno Fattizzo, MD, Marc Michel, Laetitia Languille, Juri Giannotta, MD, Henrik Frederiksen, MD Prof, Francesca Romana Mauro, MD, Bernd Jilma, Elisa Lucchini, MD, Andrea Patriarca, MD, Francesco Zaja, MD, Anita Hill, MD PhD, Sigbjorn Berentsen, MD PhD, Wilma Barcellini

Blood (2019) 134 (Supplement_1): 3516.

https://doi.org/10.1182/blood-2019-125524

Published: 2019

Journal Articles

Characteristics and Outcome of DAT-Negative Autoimmune Hemolytic Anemia: Results from a French Multicentre Observational Study

Caroline Morbieu, MD, Thierry Leblanc, MD, Marion Malphettes, MD, Charlotte Petitditdier, MD, Julie Durin, MD, Corinne Haioun, MD, Guillaume Le guenno, MD, Mikael Ebbo, MD PhD, Olivier Fain, MD, Loic Garcon, MD PhD, Aline Floch, Btissam Chami, MD, France Pirenne, MD PhD, Laetitia Languille, Bertrand Godeau, MD, Marc Michel

Blood (2018) 132 (Supplement 1): 3619.

https://doi.org/10.1182/blood-2018-99-116352

Published: 2018

Journal Articles

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

Marie Piel-Julian, Matthieu Mahévas, Johanne Germain, Laetitia Languille, Thibault Comont, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Prudhomme, Laurent Sailler, Maryse Lapeyre-Mestre, Nicolas Limal, Odile Beyne-Rauzy, Marc Michel, Daniel Adoue, Bertrand Godeau, Guillaume Moulis, MD

Blood (2017) 130 (Supplement 1): 1041.

https://doi.org/10.1182/blood.V130.Suppl_1.1041.1041

Published: 2017

Journal Articles

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

Blood (2016) 128 (22): 2555.

https://doi.org/10.1182/blood.V128.22.2555.2555

Published: 2016

Journal Articles

A Multicenter Study Evaluating the Safety of Romiplostim at Maximal Dosage for Emergency Bleeding Situations in Immune Thrombocytopenia

Mathilde Roumier, MD, Louis Terriou, MD, Mohamed Hamidou, MD PhD, Antoine Dossier, MD, Anne Sophie Morin, MD, Virginie Zarrouk, MD, Mickael Ebbo, MD, Guillaume Moulis, MD PhD, Lionel Galicier, MD, Sylvain Audia, MD PhD, Laetitia Languille, Marie Goussef, MD, Solène Poutrel, MD, Marc Michel, MD, Bertrand Godeau, MD PhD, Matthieu Mahévas, MD PhD

Blood (2016) 128 (22): 2541.

https://doi.org/10.1182/blood.V128.22.2541.2541

Published: 2016

Journal Articles

Portal or Splenic Vein Thrombosis after Splenectomy for Immune Cytopenia: A Retrospective Cohort Study

Caroline Morbieu, Francesco Brunetti, MD, Laurence Baranès, MD, Laetitia Languille, Nicolas Limal, MD, Valentine Loustau, MD, Philippe Bierling, MD PhD, Marc Michel, MD, Bertrand Godeau, MD PhD, Matthieu Mahévas, MD PhD

Blood (2015) 126 (23): 3483.

https://doi.org/10.1182/blood.V126.23.3483.3483

Published: 2015

Journal Articles

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

Lan-huong Thai, Matthieu Mahevas, MD PhD, Françoise roudot-Thoraval, Laetitia Languille, Guillaume Dumas, Mehdi Khellaf, Philippe Bierling, MD, Marc Michel, MD PhD, Bertrand Godeau, MDPhD

Blood (2014) 124 (21): 232.

https://doi.org/10.1182/blood.V124.21.232.232

Published: 2014

Journal Articles

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

Blood (2011) 118 (16): 4338–4345.

https://doi.org/10.1182/blood-2011-03-340166

Published: 2011

Includes: Supplemental data

Journal Articles

Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases.

Lilia Baili, Mehdi Khellaf, Laetitia Languille, Philippe Bierling, MD, PhD, Bertrand Godeau, Marc Michel

Blood (2009) 114 (22): 1320.

https://doi.org/10.1182/blood.V114.22.1320.1320

Published: 2009

Journal Articles

Costs of Managing Chronic Immune Thrombocytopenic Purpura (ITP) in Adults: A Retrospective Analysis.

Mehdi Khellaf, Laurent Eckert, Priscille Poitrinal, Camille Francesconi, Albert Haddad, Laetitia Languille, Philippe Bierling, MD, PhD, Marc Michel, Lionel Riou França, Robert Launois, Bertrand Godeau

Blood (2009) 114 (22): 4462.

https://doi.org/10.1182/blood.V114.22.4462.4462

Published: 2009

Journal Articles

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Blood (2009) 114 (22): 3519.

https://doi.org/10.1182/blood.V114.22.3519.3519

Published: 2009

NARROW

Long term follow-up of the STOPAGO study

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Biosimilar of Rituximab for the Treatment of Primary Immune Thrombocytopenic Purpura : A Case-Control Study

Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia

Characteristics and Outcome of DAT-Negative Autoimmune Hemolytic Anemia: Results from a French Multicentre Observational Study

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

A Multicenter Study Evaluating the Safety of Romiplostim at Maximal Dosage for Emergency Bleeding Situations in Immune Thrombocytopenia

Portal or Splenic Vein Thrombosis after Splenectomy for Immune Cytopenia: A Retrospective Cohort Study

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases.

Costs of Managing Chronic Immune Thrombocytopenic Purpura (ITP) in Adults: A Retrospective Analysis.

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only